Stocks Mount Comeback After Trump Remarks | Closing Bell

Watch on YouTube ↗  |  March 09, 2026 at 20:27  |  7:22  |  Bloomberg Markets

Summary

  • Extreme intraday volatility hit the commodities market, with WTI crude experiencing a massive $38 to $40 swing, going from up 31% to down 11% before settling 5% lower.
  • A few optimistic headlines from President Trump stating the war is "complete" triggered a massive broader market reversal, lifting the S&P 500 from a 1.5% deficit to close 0.8% higher.
  • The technology sector led the market comeback, gaining 1.8%, while financials and energy were the notable laggards of the session.
  • Single-stock catalysts dominated the tape, with massive upside moves driven by the resolution of corporate litigation (HIMS, LYV) and anticipated regulatory easing at the FDA (CAPR, RGNX).
  • Rising geopolitical tensions and spiking fuel costs are creating immediate fundamental headwinds for airlines and gig-economy platforms.
Trade Ideas
Carol Massar Anchor, Bloomberg 3:12
Novo Nordisk was said to have ended its public feud with the company, ending litigation with an agreement to actually sell its weight loss drugs on the Hims platform. By transitioning from a legal battle to a commercial partnership, Hims secures a legitimate, high-demand supply of GLP-1 drugs, which will serve as a massive revenue driver. Novo Nordisk simultaneously expands its distribution footprint in an increasingly competitive weight-loss market. LONG. The removal of legal overhang combined with a highly lucrative product partnership is a major fundamental catalyst for both equities. Increased regulatory scrutiny over telehealth prescriptions or aggressive market share capture by competitors like Eli Lilly.
Carol Massar Anchor, Bloomberg 3:43
The head of the FDA's division of vaccines and gene therapies set to leave the agency next month... to the expectation maybe a better and some more supportive landscape from the FDA for these kinds of companies. Regulatory bottlenecks are the primary headwind for clinical-stage biotechs. A change in FDA leadership that brings a more lenient or supportive stance will accelerate trial approvals and shorten the timeline to commercialization for biological and gene therapies. LONG. Anticipated deregulation acts as a sector-wide tailwind, disproportionately benefiting small-cap clinical-stage biotechs that rely on smooth FDA pathways. Clinical trials could still fail on efficacy or safety grounds regardless of who is leading the FDA division.
Carol Massar Anchor, Bloomberg 4:47
Live Nation and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities... it would reportedly open up parts of Live Nation's ticketing arm to third party sellers. While the company is making operational concessions to allow third-party sellers, settling with the DOJ removes a massive existential and legal cloud over the stock. Markets reward certainty, allowing investors to refocus on the company's dominant position in live entertainment. LONG. The resolution of federal antitrust litigation typically triggers a relief rally and multiple expansion as worst-case breakup scenarios are priced out. The concessions made to third-party sellers could erode Ticketmaster's market share and profit margins more than the market currently anticipates.
Carol Massar Anchor, Bloomberg 5:21
Coherent, of course, is going to be added to the S&P 500 at the end of March 23rd. Inclusion in a major benchmark index forces passive index funds and ETFs to purchase the stock to match the index weighting, creating guaranteed, price-agnostic buying pressure. LONG. Index inclusion is a classic structural catalyst that drives short-term capital inflows and price appreciation. The inclusion rally is often front-run by institutional investors, which can lead to a sell-the-news pullback once the stock is officially added to the index.
Katie Greifeld Anchor, Bloomberg 5:52
The Iran war has airlines reviewing growth plans as fuel costs rise. We heard that some airlines were considering halting jet deliveries... and pause leasing and order discussions. Spiking oil prices squeeze airline operating margins. To preserve cash, airlines will delay capital expenditures, which directly hits Boeing's order book, delivery schedule, and future cash flow visibility. SHORT. Macroeconomic and geopolitical pressures on airlines translate directly into delayed revenue and worsening fundamentals for aircraft manufacturers. A sudden de-escalation in geopolitical conflicts could drop oil prices, causing airlines to quickly resume their expansion and fleet upgrade plans.
Katie Greifeld Anchor, Bloomberg 6:24
These companies actually have exposure to the costs for fuel oil and the idea that all this pressure could really trickle out into the consumer and make things more expensive. Gig-economy delivery and ride-hailing networks rely on drivers who bear the cost of fuel. As gas prices spike, platforms must implement surcharges to retain their driver supply. These higher costs are passed directly to consumers, which can destroy demand for highly discretionary services. SHORT. Spiking energy costs act as a double-edged sword, squeezing driver supply while simultaneously killing consumer demand through higher end-pricing. Oil prices could stabilize quickly, or these platforms may possess enough pricing power that consumers absorb the surcharges without reducing their order volume.
Katie Greifeld Anchor, Bloomberg 6:57
Paramount did win here. So we do see shares down about 6.7% on the day after Tencent said it intends to invest several hundred million dollars. The ongoing M&A saga involving Skydance, Netflix, and now Tencent creates a highly volatile and unpredictable environment. While capital injections are generally positive, the complex bidding wars and strategic shifts make the stock's near-term direction unclear. WATCH. The corporate situation is too fluid and headline-driven for a high-conviction directional trade until the final structure and valuation are confirmed. Remaining on the sidelines means potentially missing out on a sudden buyout premium if a definitive, high-value acquisition is announced.
Up Next

This Bloomberg Markets video, published March 09, 2026, features Carol Massar, Katie Greifeld discussing NVO, HIMS, CAPR, RGNX, LYV, COHR, BA, UBER, DASH, PARA. 7 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Carol Massar, Katie Greifeld  · Tickers: NVO, HIMS, CAPR, RGNX, LYV, COHR, BA, UBER, DASH, PARA